Affiliation: Department of Cardiac Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

Dr. Kai Xing, PhD, specializes in atherosclerotic cardiovascular disease and heart transplantation in end-stage heart failure. His research integrates multi-omics approaches, including single-cell transcriptomics, metabolomics, and spatial omics, utilizing human specimens and animal models (mouse, rat, pig, monkey). Dr. Xing has expertise in allotransplantation, focusing on donor pool expansion, organ preservation, acute rejection, and cardiac allograft vasculopathy (CAV), as well as xenotransplantation, with an emphasis on gene editing and immune rejection. Additionally, he investigates heart-brain interactions in cardio-cerebral comorbidities, aiming to enhance transplantation outcomes and develop novel therapeutic strategies.